Hubei Xingfa Chemicals Group Co., Ltd. (SHA:600141)
China · Delayed Price · Currency is CNY 33.04
+0.16 (0.49%)
Apr 10, 2026, 3:00 PM CST
SHA:600141 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 29,300 | 27,953 | 27,741 | 29,593 | 23,332 |
Other Revenue | - | 443.9 | 540.3 | 717.79 | 570.02 |
| 29,300 | 28,396 | 28,281 | 30,311 | 23,902 | |
Revenue Growth (YoY) | 3.18% | 0.41% | -6.69% | 26.81% | 30.49% |
Cost of Revenue | 24,038 | 23,072 | 23,902 | 19,685 | 15,919 |
Gross Profit | 5,261 | 5,325 | 4,380 | 10,626 | 7,983 |
Selling, General & Admin | 934.25 | 1,008 | 832.85 | 823.21 | 641.17 |
Research & Development | 1,314 | 1,183 | 1,117 | 1,232 | 862.18 |
Other Operating Expenses | 304.54 | 481.5 | 322.47 | 256.33 | 205.07 |
Operating Expenses | 2,553 | 2,686 | 2,269 | 2,314 | 1,699 |
Operating Income | 2,708 | 2,639 | 2,110 | 8,312 | 6,284 |
Interest Expense | - | -395.18 | -327.54 | -364.36 | -520.05 |
Interest & Investment Income | 157.43 | 144.11 | 161.66 | 316.46 | 310.69 |
Currency Exchange Gain (Loss) | - | 68.08 | 36.13 | 80.44 | -6.14 |
Other Non Operating Income (Expenses) | -518.71 | -71.19 | -124.72 | -125.52 | -119.83 |
EBT Excluding Unusual Items | 2,347 | 2,385 | 1,856 | 8,219 | 5,948 |
Impairment of Goodwill | - | -233.89 | -120.3 | -24.59 | -2.52 |
Gain (Loss) on Sale of Investments | 1.59 | -22.65 | 8.73 | -100.88 | 0.41 |
Gain (Loss) on Sale of Assets | 3.23 | -63.04 | -91.03 | -297.25 | -466.05 |
Asset Writedown | -187.3 | -0.45 | -27.23 | -22.88 | -127.43 |
Other Unusual Items | - | 18.97 | 119.28 | 97.62 | 70.71 |
Pretax Income | 2,165 | 2,083 | 1,745 | 7,871 | 5,423 |
Income Tax Expense | 552.46 | 464.7 | 336.67 | 1,074 | 689.58 |
Earnings From Continuing Operations | 1,612 | 1,619 | 1,409 | 6,796 | 4,734 |
Minority Interest in Earnings | -120.22 | -17.39 | -7.96 | -944.61 | -452.12 |
Net Income | 1,492 | 1,601 | 1,401 | 5,852 | 4,282 |
Net Income to Common | 1,492 | 1,601 | 1,401 | 5,852 | 4,282 |
Net Income Growth | -6.83% | 14.33% | -76.06% | 36.67% | 589.24% |
Shares Outstanding (Basic) | 1,105 | 1,104 | 1,121 | 1,102 | 1,104 |
Shares Outstanding (Diluted) | 1,139 | 1,144 | 1,197 | 1,123 | 1,112 |
Shares Change (YoY) | -0.43% | -4.45% | 6.59% | 0.99% | 7.41% |
EPS (Basic) | 1.35 | 1.45 | 1.25 | 5.31 | 3.88 |
EPS (Diluted) | 1.31 | 1.40 | 1.17 | 5.21 | 3.85 |
EPS Growth | -6.43% | 19.66% | -77.54% | 35.33% | 541.67% |
Free Cash Flow | -633.84 | 85.24 | -1,096 | 4,520 | 3,827 |
Free Cash Flow Per Share | -0.56 | 0.07 | -0.92 | 4.02 | 3.44 |
Dividend Per Share | - | 1.000 | 0.600 | 1.000 | 0.500 |
Dividend Growth | - | 66.67% | -40.00% | 100.00% | 100.00% |
Gross Margin | 17.96% | 18.75% | 15.49% | 35.06% | 33.40% |
Operating Margin | 9.24% | 9.29% | 7.46% | 27.42% | 26.29% |
Profit Margin | 5.09% | 5.64% | 4.95% | 19.31% | 17.91% |
Free Cash Flow Margin | -2.16% | 0.30% | -3.88% | 14.91% | 16.01% |
EBITDA | 5,486 | 4,927 | 4,145 | 9,974 | 7,547 |
EBITDA Margin | 18.73% | 17.35% | 14.66% | 32.91% | 31.57% |
D&A For EBITDA | 2,778 | 2,288 | 2,034 | 1,662 | 1,263 |
EBIT | 2,708 | 2,639 | 2,110 | 8,312 | 6,284 |
EBIT Margin | 9.24% | 9.29% | 7.46% | 27.42% | 26.29% |
Effective Tax Rate | 25.52% | 22.30% | 19.29% | 13.65% | 12.72% |
Revenue as Reported | - | 28,396 | 28,281 | 30,311 | 23,902 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.